AMPICILLIN FOR INJECTION, USP 1 G — DIN 02227002
AMPICILLIN (AMPICILLIN SODIUM) : 1 G · FRESENIUS KABI CANADA LTD · POWDER FOR SOLUTION · wholesale supply in Canada
Health Canada status: MARKETED
What is AMPICILLIN FOR INJECTION, USP?
AMPICILLIN FOR INJECTION, USP 1 G contains AMPICILLIN (AMPICILLIN SODIUM) : 1 G. It is listed in the Health Canada Drug Product Database under DIN 02227002, held by FRESENIUS KABI CANADA LTD, supplied as POWDER FOR SOLUTION for INTRAMUSCULAR ; INTRAVENOUS administration. Health Canada currently lists it as marketed, status dated 16-Aug-2019. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is AMPICILLIN FOR INJECTION, USP used for?
The treatment of infections due to susceptible gram-negative organisms (including strains of Shigellae, S. typhosa and other salmonellae, E. coli, H. influenzae, and P. mirabilis) and susceptible gram-positive organisms [including streptococci, pneumococci, and non-beta-lactamase (penicillinase) producing staphylococci]. To reduce the development of drug‐resistant bacteria and maintain the effectiveness of Ampicillin for Injection, USP and other antibacterial drugs, Ampicillin for Injection, USP should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
How much does Ampicillin cost around the world?
Ampicillin is listed on 7 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Bahrain publishes a retail (max); Czechia publishes a max producer price (ex-factory); Greece publishes a producer price (ex-factory). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| Romania | max producer price | 14 | 34 | RON███.██ |
| South Africa | single exit price | 17 | 24 | ZAR███.██ |
| Saudi Arabia | public | 12 | 12 | SAR███.██ |
| Czechia | max producer price (ex-factory) | 3 | 6 | CZK███.██ |
| Greece | producer price (ex-factory) | 3 | 3 | EUR███.██ |
| United States | acquisition | 1 | 3 | USD███.██ |
| Bahrain | retail (max) | 1 | 2 | BHD███.██ |
84 pack listings across 51 brand entries and 7 price bases, refreshed 03 Sep 2026. Ranges span every Ampicillin pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Ampicillin in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
16 holders have a Canadian DIN containing Ampicillin, across 56 DINs, of which 17 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| TEVA CANADA LIMITED | 6 | 6 | AMPICILLIN SODIUM FOR INJECTION, USP, TEVA-AMPICILLIN | Sourceable in Canada |
| FRESENIUS KABI CANADA LTD | 5 | 4 | AMPICILLIN FOR INJECTION, AMPICILLIN FOR INJECTION, USP | Sourceable in Canada |
| AURO PHARMA INC | 4 | 4 | AMPICILLIN SODIUM FOR INJECTION BP | Sourceable in Canada |
| EUGIA PHARMA INC. | 4 | 3 | AMPICILLIN SODIUM FOR INJECTION BP | Sourceable in Canada |
| AYERST LABORATORIES | 5 | 0 | PENBRITIN CAP 250MG, PENBRITIN INJ 2000MG, PENBRITIN INJ 250MG, PENBRITIN INJ 500MG, PENBRITIN PWS 250MG/5ML | No marketed DIN |
| BRISTOL LABS DIVISION OF BRISTOL-MYERS SQUIBB | 5 | 0 | AMPICIN FOR INJECTION 250MG, AMPICIN INJ 125MG/VIAL, AMPICIN INJ 1GM, AMPICIN INJ 2000MG, AMPICIN INJ 500MG | No marketed DIN |
| STERIMAX INC | 5 | 0 | AMPICILLIN FOR INJECTION, USP | No marketed DIN |
| APOTEX INC | 4 | 0 | APO AMPI CAPSULES 250MG, APO AMPI CAPSULES 500MG, APO AMPI LIQ 125MG/5ML, APO AMPI LIQ 250MG/5ML | No marketed DIN |
| NU-PHARM INC | 4 | 0 | NU-AMPI CAPSULES 250MG, NU-AMPI CAPSULES 500MG, NU-AMPI SUS 125MG/5ML, NU-AMPI SUSPENSION 250MG/5ML | No marketed DIN |
| NOVOPHARM LIMITED | 3 | 0 | NOVO-AMPICILLIN PWS 500MG/5ML, NOVO-AMPICILLIN SUS 125MG/5ML, NOVO-AMPICILLIN SUS 250MG/5ML | No marketed DIN |
| WYETH-AYERST CANADA INC. | 3 | 0 | PENBRITIN-1000 PWS 1000MG/VIAL, PENBRITIN-125 PWS 125MG/VIAL, PENBRITIN-250 PWS IM/IV 250MG/VIAL | No marketed DIN |
| PRO DOC LIMITEE | 2 | 0 | PRO AMPI 250 CAP 250MG, PRO AMPI 500 CAP 500MG | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 1 G |
|---|---|
| Dosage form | POWDER FOR SOLUTION |
| Route | INTRAMUSCULAR ; INTRAVENOUS |
| Pack configuration (monograph) | 250 mg, 500 mg, 1 g and 2 g per vial |
| Storage | Store the dry powder at controlled room temperature between 15 °C and 30 °C. Reconstituted solutions should be used within one hour when kept at controlled room temperature between 15 °C and 30 °C. Protect reconstituted solutions from freezing. |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Ampicillin |
|---|---|
| ATC code | J01CA01 |
| AHFS class | 08:12.16.08 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02227002 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2227002 |
| Brand name | AMPICILLIN FOR INJECTION, USP |
| Generic / active ingredient | AMPICILLIN (AMPICILLIN SODIUM) : 1 G |
| Market authorization holder | FRESENIUS KABI CANADA LTD |
| Health Canada schedule | Prescription |
| ATC code | J01CA01 |
| ATC anatomical main group | J — Anti-infectives for systemic use |
| ATC therapeutic subgroup | J01CA |
| Current status | MARKETED |
| Status date | 16-Aug-2019 |
| Original market date | 1998-08-14 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
Is Ampicillin in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Resolved — reported by TEVA CANADA LIMITED, last seen 09 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
17 of 56 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| AMPICILLIN FOR INJECTION, USP | 500 MG | POWDER FOR SOLUTION | FRESENIUS KABI CANADA LTD | MARKETED | 02227010 |
| AMPICILLIN FOR INJECTION, USP | 2 G | POWDER FOR SOLUTION | FRESENIUS KABI CANADA LTD | MARKETED | 02226995 |
| AMPICILLIN FOR INJECTION, USP | 250 MG | POWDER FOR SOLUTION | FRESENIUS KABI CANADA LTD | MARKETED | 02227029 |
| AMPICILLIN SODIUM FOR INJECTION BP | 1 G | POWDER FOR SOLUTION | EUGIA PHARMA INC. | MARKETED | 02530503 |
| AMPICILLIN SODIUM FOR INJECTION BP | 2 G | POWDER FOR SOLUTION | AURO PHARMA INC | MARKETED | 02462346 |
| AMPICILLIN SODIUM FOR INJECTION BP | 500 MG | POWDER FOR SOLUTION | AURO PHARMA INC | MARKETED | 02462311 |
| AMPICILLIN SODIUM FOR INJECTION BP | 250 MG | POWDER FOR SOLUTION | AURO PHARMA INC | MARKETED | 02462303 |
| AMPICILLIN SODIUM FOR INJECTION BP | 1 G | POWDER FOR SOLUTION | AURO PHARMA INC | MARKETED | 02462338 |
| AMPICILLIN SODIUM FOR INJECTION BP | 500 MG | POWDER FOR SOLUTION | EUGIA PHARMA INC. | MARKETED | 02530481 |
| AMPICILLIN SODIUM FOR INJECTION BP | 2 G | POWDER FOR SOLUTION | EUGIA PHARMA INC. | MARKETED | 02530511 |
2 · Same class — other molecules in ATC J01CA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Amoxicillin | AG-AMOXICILLIN · AMOX 250 CAP 250MG · AMOX 500 CAP 500MG · AMOX S 125 SUS 125MG/5ML · +54 more | 121 | 30 | Yes |
| Ampicillin | AMPICILLIN FOR INJECTION · AMPICILLIN FOR INJECTION, USP · AMPICILLIN SODIUM FOR INJECTION BP · AMPICILLIN SODIUM FOR INJECTION, USP · +33 more | 56 | 17 | Yes |
| Piperacillin | PIPERACILLIN FOR INJECTION · PIPRACIL INJ 2GM/VIAL · PIPRACIL INJ 3GM/VIAL · PIPRACIL INJ 4GM/VIAL · +5 more | 14 | 0 | Not in Canada |
| Pivmecillinam | SELEXID · SELEXID TAB 185MG | 3 | 0 | Not in Canada |
| Bacampicillin | PENGLOBE TAB 400 MG · PENGLOBE TAB 800 MG | 2 | 0 | Not in Canada |
| Pivampicillin | PONDOCILLIN PWS 175MG/5ML · PONDOCILLIN TAB 500MG | 2 | 0 | Not in Canada |
| Ticarcillin | TICAR INJ PWS 1GM/VIAL · TICAR INJ PWS 3GM/VIAL | 2 | 0 | Not in Canada |
| Ampicillin, Combinations | PRO BIOSAN KIT | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC J01C
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| J01CR | Amoxicillin And Beta-Lactamase Inhibitor · Piperacillin And Beta-Lactamase Inhibitor · Ticarcillin And Beta-Lactamase Inhibitor | 113 | 44 |
| J01CF | Beta-Lactamase Resistant Penicillins · Cloxacillin · Flucloxacillin | 42 | 9 |
| J01CE | Benzathine Benzylpenicillin · Benzathine Phenoxymethylpenicillin · Benzylpenicillin · Combinations · Phenoxymethylpenicillin · +1 more | 69 | 4 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is AMPICILLIN FOR INJECTION, USP called?
The same molecule, Ampicillin, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| AMPICILLIN ARDEZ | Latin | Czechia |
| AMPICILIN BBP | Latin | Czechia |
| EPICOCILLIN | Latin | Bahrain |
| Petercillin | Latin | South Africa |
| AMPICILIN AVMC | Latin | Czechia |
| Ampouleipen | Latin | South Africa |
| Be-Ampicil | Latin | South Africa |
| Be-Ampouleicil | Latin | South Africa |
| Cloxam | Latin | South Africa |
| Megamox | Latin | South Africa |
| Megamox S | Latin | South Africa |
| Megapen S | Latin | South Africa |
| Novactam | Latin | Saudi Arabia |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.